Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-04-27

FDA Approved: REVATIO — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA is handling a supplemental approval application for Revatio (sildenafil citrate) submitted by Viatris Specialty LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • REVATIO (SILDENAFIL CITRATE)

Snippet

SUPPL AP for REVATIO (SILDENAFIL CITRATE)